Speakers | World Medical Innovation Forum - Gene and Cell Therapy

Speakers

2022 Forum speakers included CEOs of leading companies in the GCT and biotech fields, investors, entrepreneurs, Harvard clinicians and scientists, government officials and other key influencers.

C-Suite Speakers

Irina Antonijevic, MD, PhD 

CMO and Head of R&D, Triplet Therapeutics, Inc.

James Beck, PhD 

CSO, Parkinson’s Foundation

Albert Bourla, PhD 

CEO, Pfizer Inc.

Sarah Boyce 

President & CEO, Avidity Biosciences, Inc.

Robert Bradway 

CEO, Amgen

Jim Burns, PhD 

CEO, Locanabio

Pablo Cagnoni, MD 

CEO, Rubius Therapeutics

Marc Casper 

CEO, ThermoFisher

Monica Coenraads 

CEO, Rett Syndrome Research Trust

Christina Coughlin, MD, PhD 

CEO, CytoImmune

Rick Fair 

President & CEO, Bellicum

Alexandria Forbes, PhD 

President & CEO, MeiraGTx

David Hallal 

Chairman & CEO, ElevateBio

Rachel Haurwitz, PhD 

President & CEO, Caribou Biosciences

Colin Hill 

CEO, GNS Healthcare

Rosana Kapeller, MD, PhD 

Co-Founder, President & CEO, ROME Therapeutics

Sekar Kathiresan, MD 

CEO, Verve Therapeutics

Jason Kelly, PhD 

Co-Founder & CEO, Ginkgo Bioworks

Anne Klibanski, MD 

President & CEO, Mass General Brigham Laurie Carrol Guthart Professor of Medicine, HMS

Nick Leschly 

CEO, 2seventy bio

Josh Mandel-Brehm 

President & CEO, CAMP4 Therapeutics

Geoff McDonough, MD 

CEO, Generation Bio

Rachel McMinn, PhD 

Founder & CEO, Neurogene

Maria Millan, MD 

President & CEO, California Institute for Regenerative Medicine

Rick Modi 

CEO, Affinia Therapeutics

Brian Moynihan 

Chair & CEO, Bank of America

Michael Paglia 

COO, ElevateBio BaseCamp, ElevateBio

Spyros Papapetropoulos, MD, PhD 

CMO, Vigil Neuroscience

Harith Rajagopalan, MD, PhD 

CEO & Co-Founder, Fractyl Health

Dhvanit Shah, PhD 

President & CEO, Garuda Therapeutics

Christi Shaw 

CEO, Kite, a Gilead Company

Adam Shaywitz, MD, PhD 

CMO, BridgeBio Gene Therapy

Rahul Singhvi, ScD 

CEO, National Resilience, Inc.

Daniel Skovronsky, MD, PhD 

Senior Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company

Scott Sperling 

Co-Chief Executive Officer, Thomas H. Lee Partners Chairman of the Board of Directors, Mass General Brigham

Catherine Stehman-Breen, MD 

CEO, Chroma Medicine

Ravi Thadhani, MD 

Chief Academic Officer, Mass General Brigham

Rusty Williams, MD, PhD 

Chairman & CEO, Walking Fish Therapeutics

Ran Zheng 

CEO, Landmark Bio

Speakers

Laura Aguilar, MD, PhD  

Co-Founder, Candel Therapeutics

Tazeen Ahmad  

Managing Director, Global Research, BofA Securities

Galit Alter, PhD  

Principal Investigator, Ragon Institute, MGH Professor of Medicine, HMS

Irina Antonijevic, MD, PhD  

CMO and Head of R&D, Triplet Therapeutics, Inc.

Natalie Artzi, PhD  

Assistant Professor of Medicine, HMS

Christopher Baum, MD  

Chairman of the Board of Directors, Berlin Institute of Health at Charité (BIH)

James Beck, PhD  

CSO, Parkinson’s Foundation

Fengfeng Bei, PhD  

Principal Investigator, Department of Neurosurgery, BWH Assistant Professor of Neurosurgery, HMS

Paul Biddinger, MD  

Chief Preparedness and Continuity Officer, Mass General Brigham Associate Professor of Emergency Medicine, HMS

John Bishai, PhD  

Managing Director, Global Investment Banking, BofA Securities

Joseph Bonventre, MD, PhD  

Chief, Division of Renal Medicine, BWH Samuel A. Levine Distinguished Professor of Medicine and Constantine L. Hampers Distinguished Chair, HMS

Albert Bourla, PhD  

CEO, Pfizer Inc.

Sarah Boyce  

President & CEO, Avidity Biosciences, Inc.

Robert Bradway  

CEO, Amgen

Helen Branswell  

Senior Writer, STAT

David Brown, MD  

President, Massachusetts General Hospital Executive Vice President, Mass General Brigham

Lynn Bry, MD, PhD  

Director, Massachusetts Host-Microbiome Center, BWH Associate Professor of Pathology, HMS

Jim Burns, PhD  

CEO, Locanabio

Greg Butz  

Managing Director, Head of Life Sciences Investment Banking, BofA Securities

Pablo Cagnoni, MD  

CEO, Rubius Therapeutics

Robert Califf, MD  

Commissioner of Food and Drugs, US Food and Drug Administration

Bob Carter, MD, PhD  

Chairman, Department of Neurosurgery, MGH William and Elizabeth Sweet Professor of Neurosurgery, HMS

Marc Casper  

CEO, ThermoFisher

Miceal Chamberlain  

President of Massachusetts, Northeast Region Executive, Bank of America

Anil Chandraker, MD  

Medical Director of Kidney and Pancreas Transplantation, BWH Associate Professor of Medicine, HMS

Zheng-Yi Chen, DPhil  

Associate Scientist, Eaton-Peabody Laboratories, Mass Eye and Ear Associate Professor of Otolaryngology Head and Neck Surgery, HMS

Nino Chiocca, MD, PhD  

Neurosurgeon-in-Chief and Chairman, Neurosurgery, BWH Harvey W. Cushing Professor of Neurosurgery, HMS

Choi-Fong Cho, PhD  

Assistant Professor of Neurosurgery, BWH, HMS

Shelley Chu, MD, PhD  

Partner, Lightspeed

Chris Coburn  

Chief Innovation Officer, Mass General Brigham

Monica Coenraads  

CEO, Rett Syndrome Research Trust

Bertha Coombs  

Reporter, CNBC

David Corey, PhD  

Bertarelli Professor of Translational Medical Science, Neurobiology, HMS

Susan Cotman, PhD  

Assistant in Neuroscience, Center for Genomic Medicine, MGH Assistant Professor of Neurology, HMS

Christina Coughlin, MD, PhD  

CEO, CytoImmune

Merit Cudkowicz, MD  

Chair, Dept of Neurology, MGH Julieanne Dorn Professor of Neurology, HMS

Derik de Bruin, PhD  

Managing Director, Global Research, BofA Securities

Albert Edge, PhD  

Eaton Peabody Professor of Otolaryngology, HMS, Mass Eye and Ear

Florian Eichler, MD  

Director, Center for Rare Neurological Diseases, MGH Associate Professor of Neurology, HMS

Seth Ettenberg, PhD  

President & CEO, BlueRock Therapeutics

Rick Fair  

President & CEO, Bellicum

Anne Finucane  

Chairman of the Board, Bank of America Europe

John Fish  

Chairman & CEO, Suffolk Chair, Brigham and Women’s Hospital

Meredith Fisher, PhD  

Partner, Mass General Brigham Ventures

Alexandria Forbes, PhD  

President & CEO, MeiraGTx

Jean-François Formela, MD  

Partner, Atlas Venture

Christine Fox  

President, Novartis Gene Therapies

Matthew Frigault, MD  

Clinical Director, Cellular Immunotherapy Program, MGH Assistant Professor of Medicine, HMS

Nicholas Galakatos, PhD  

Global Head of Life Sciences, Blackstone

Annie Ganot  

VP, Head of Patient Advocacy, Solid Biosciences

Jason Gerberry  

Managing Director, Global Research, BofA Securities

Michael Gilmore, PhD  

Chief Scientific Officer, Mass Eye and Ear Sir William Osler Professor of Ophthalmology, HMS

Allan Goldstein, MD  

Chief of Pediatric Surgery, MGH Surgeon-in-Chief, MassGeneral for Children ,

Robert Green, MD  

Director, Genomes2People Research Program, BWH Professor of Medicine, HMS

Yulia Grishchuk, PhD  

Assistant Investigator, Center for Genomic Medicine, MGH Assistant Professor of Neurology, HMS

Stephen Haggarty, PhD  

Director, Chemical Neurobiology Laboratory, Center for Genomic Medicine, MGH Associate Professor of Neurology, HMS

David Hallal  

Chairman & CEO, ElevateBio

Alexandria Hammond, PhD  

Associate, Global Research, BofA Securities

Erin Harris  

Chief Editor, Cell & Gene

Greg Harrison  

Vice President, Global Research, BofA Securities

Rachel Haurwitz, PhD  

President & CEO, Caribou Biosciences

Kristen Hege, MD  

Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, Bristol Myers Squibb

Todd Herrington, MD, PhD  

Director, Deep Brain Stimulation Program, MGH Assistant Professor of Neurology, HMS

Robert Higgins, MD, MSHA  

President, Brigham and Women’s Hospital Executive Vice President, Mass General Brigham

Colin Hill  

CEO, GNS Healthcare

Susan Hockfield, PhD  

President Emerita, MIT

Ole Isacson, MD, PhD  

Director, Neuroregeneration Research Institute, McLean Professor of Neurology & Neuroscience, HMS

Max Jan, PhD  

Principal Investigator, Center for Cancer Research, MGH Assistant Professor of Pathology, HMS

J. Keith Joung, MD, PhD  

Robert B. Colvin, M.D. Endowed Chair in Pathology & Pathologist, MGH Professor of Pathology, HMS

Carl June, MD  

Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine

Staci Kallish, DO  

President, Board of Directors, National Tay Sachs and Allied Diseases Medical Geneticist, Associate Professor of Clinical Medicine, Penn Medicine

Rosana Kapeller, MD, PhD  

Co-Founder, President & CEO, ROME Therapeutics

Sekar Kathiresan, MD  

CEO, Verve Therapeutics

Jason Kelly, PhD  

Co-Founder & CEO, Ginkgo Bioworks

Kwang-Soo Kim, PhD  

Director, Molecular Neurobiology Laboratory, McLean Professor of Neuroscience and Psychiatry, HMS

Roger Kitterman  

VP, Mass General Brigham Ventures

Anne Klibanski, MD  

President & CEO, Mass General Brigham Laurie Carrol Guthart Professor of Medicine, HMS

Stephen Knight, MD  

President & Managing Partner, F-Prime Capital

Adam Koppel, MD, PhD  

Managing Director, Bain Capital Life Sciences

Jonathan Kraft  

President, The Kraft Group Chairman of the Board of Trustees, MGH

Anna Krichevsky, PhD  

Associate Professor of Neurology, BWH, HMS

Daniel Krizek  

Portfolio Manager, Citadel

Daniel Kuritzkes, MD  

Chief, Division of Infectious Diseases, BWH Harriet Ryan Albee Professor of Medicine, HMS

Jeannie Lee, MD, PhD  

Molecular Biologist, MGH Professor of Genetics, HMS

Nick Leschly  

CEO, 2seventy bio

Josh Mandel-Brehm  

President & CEO, CAMP4 Therapeutics

Joel Marcus  

Executive Chairman & Founder, Alexandria Real Estate Equities, Inc.

James Markmann, MD, PhD  

Chief, Division of Transplant Surgery, MGH Claude E. Welch Professor of Surgery, HMS

Peter Marks, MD, PhD  

Director, Center for Biologics Evaluation and Research, FDA

Marcela Maus, MD, PhD  

Director, Cellular Immunotherapy Program, Cancer Center, MGH Associate Professor, Medicine, HMS

Terry McGuire  

Founding Partner, Polaris Partners

Rachel McMinn, PhD  

Founder & CEO, Neurogene

Geoff Meacham  

Managing Director, Global Research, BofA Securities

Maria Millan, MD  

President & CEO, California Institute for Regenerative Medicine

Marco Mineo, MD  

Instructor in Neurosurgery, BWH, HMS

Rick Modi  

CEO, Affinia Therapeutics

Brian Moynihan  

Chair & CEO, Bank of America

Sumit Mukherjee  

Managing Director & Head of Healthcare in Equity Capital Markets, BofA Securities

Richard Mulligan, PhD  

Mallinckrodt Professor of Genetics, Emeritus, HMS Executive Vice Chairman, Sana Biotechnology, Inc

Christopher Murphy  

Vice President Viral Vector Services, Thermo Fisher

Luigi Naldini, MD, PhD  

Director, San Raffaele Telethon Institute for Gene Therapy

Amir Nashat, PhD  

Managing Partner, Polaris Ventures

Sarah Nikiforow, MD, PhD  

Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Cell Therapy Program, DFCI Assistant Professor, HMS

Rebecca Oberman, PhD  

Executive Director, Mucolipidosis Type IV (ML4) Foundation

Michael Paglia  

COO, ElevateBio BaseCamp, ElevateBio

Spyros Papapetropoulos, MD, PhD  

CMO, Vigil Neuroscience

Pierpaolo Peruzzi, MD, PhD  

Neurosurgeon and Principal Investigator, BWH Assistant Professor of Neurosurgery, HMS

Andrew Plump, MD, PhD  

President, R&D, Takeda

Mark Poznansky, MD, PhD  

Director, Vaccine and Immunotherapy Center, MGH Professor of Medicine, HMS

Francisco Quintana, PhD  

Professor, Neurology, Ann Romney Center for Neurologic Diseases, BWH Kuchroo Weiner Distinguished Professor of Neuroimmunology, BWH

Harith Rajagopalan, MD, PhD  

CEO & Co-Founder, Fractyl Health

Vijaya Ramesh, PhD  

Co-Director of Neuroscience, Associate Geneticist in Neurology, MGH Professor of Neurology, HMS

Richard Ransohoff, MD  

CMO, Abata Therapeutics Venture Partner, Third Rock Ventures

Arati Rao, MD  

Senior Vice President, Clinical Development, PACT Pharma

Kendra Rose, PhD  

VP, Head of New Platforms, Ophthalmology and Hemophilia, Bayer

John Rossi  

VP Head of Translational Medicine, Syncopation Life Sciences

Issi Rozen  

Venture Partner, GV

Michael Ryskin  

Director, Global Research, BofA Securities

Bastiano Sanna, PhD  

EVP, Chief of Cell & Gene Therapies and VCGT Site Head, Vertex Pharmaceuticals

Vicki Sato, PhD  

Chairman of the Board, Vir Biotechnology Chairman, Denali Therapeutics

David Scadden, MD  

Director, Center for Regenerative Medicine, MGH Gerald and Darlene Jordan Professor of Medicine, HMS

Jeffrey Schweitzer, MD, PhD  

Neurosurgeon, MGH Assistant Professor of Neurosurgery, HMS

Christine Seidman, MD  

Director, Cardiovascular Genetics Center, BWH Smith Professor of Medicine & Genetics, HMS

Laura Sepp-Lorenzino, PhD  

Chief Scientific Officer, Executive Vice President, Intellia Therapeutics

Dhvanit Shah, PhD  

President & CEO, Garuda Therapeutics

Khalid Shah, PhD  

Vice Chairman of Research, Department of Neurosurgery, BWH Professor, HMS

Phillip Sharp, PhD  

Institute Professor and Professor of Biology, Koch Institute for Integrative Cancer Research at MIT Co-Founder, Alnylam Pharmaceuticals, Inc.

Norman Sharpless, MD  

Former Director, National Cancer Institute

Christi Shaw  

CEO, Kite, a Gilead Company

Adam Shaywitz, MD, PhD  

CMO, BridgeBio Gene Therapy

Angela Shen, MD  

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

Erica Shenoy, MD, PhD  

Associate Chief, Infection Control Unit, MGH Associate Professor of Medicine, HMS

Rahul Singhvi, ScD  

CEO, National Resilience, Inc.

Daniel Skovronsky, MD, PhD  

Senior Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company

Susan Slaugenhaupt, PhD  

Scientific Director and Elizabeth G. Riley and Daniel E. Smith Jr. Endowed Chair, Mass General Research Institute Professor, Neurology, HMS

Scott Sperling  

Co-Chief Executive Officer, Thomas H. Lee Partners Chairman of the Board of Directors, Mass General Brigham

Catherine Stehman-Breen, MD  

CEO, Chroma Medicine

Beth Stevens, PhD  

HHMI Investigator, F.M. Kirby Neurobiology Research Program, Boston Children’s Hospital Associate Professor of Neurology, HMS

Alec Stranahan, PhD  

Vice President, Equity Research, BofA Securities

Bakhos Tannous, PhD  

Director, Experimental Therapeutics Unit, Director, Viral Vector Core, MGH Professor of Neurology, HMS

Rudolph Tanzi, PhD  

Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH Joseph P. and Rose F. Kennedy Professor of Neurology, HMS

Ravi Thadhani, MD  

Chief Academic Officer, Mass General Brigham

Luk Vandenberghe, PhD  

Grousbeck Associate Professor in Gene Therapy, Mass General Brigham (on leave)

Demetrios Vavvas, MD, PhD  

Associate Director of the Retina Service, Mass Eye and Ear Solman and Libe Friedman Professor of Ophthalmology, Co-Director Ocular Regenerative Medical Institute, HMS

Rusty Williams, MD, PhD  

Chairman & CEO, Walking Fish Therapeutics

Janet Wu  

Anchor/Reporter, Bloomberg

Michael Young, PhD  

Director, Minda de Gunzburg Center for Retinal Regeneration, Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear Associate Professor of Ophthalmology, Co-Director, Ocular Regenerative Medicine Institute, HMS

Richard Young, PhD  

Professor, Whitehead Institute, MIT

Nerea Zabaleta, PhD  

Principal Investigator, Grousbeck Gene Therapy Center, Mass Eye and Ear Instructor in Ophthalmology, HMS

Jason Zemansky, PhD  

Vice President, Global Research, BofA Securities

Ran Zheng  

CEO, Landmark Bio